RESCHEDULED- 3rd Annual Cedars-Sinai Gastrointestinal Tumor Conference: Advances in Immunotherapy for Gastrointestinal Cancers

The third annual Cedars-Sinai Gastrointestinal Tumor Conference will provide concise and comprehensive updates on the most recent research and advances in immunotherapy for gastrointestinal cancers. A stellar faculty has been assembled to share developments in precision medicine, research, and immunotherapeutic approaches to the treatment of cancers of the pancreas, liver, and gastric/esophagus. Invited faculty will present a comprehensive bench to bedside review of immune therapy for GI malignancies, detail immune therapies for pancreatic cancer, and explore advances in biomarkers and immunotherapy in gastroesophageal cancers. Biomarker strategies for Immunotherapy in neuroendocrine and rare tumors will be presented and participants will also have an opportunity to review immune-related toxicities and the results of combining radiation and immunotherapy. Join your colleagues on April 25 for this important half day educational activity that will enhance your understanding of GI cancers and provide you with valuable information to inform your clinical decision-making and treatment approaches for your patients.

In collaboration with 

1. Consider advances in biomarkers and immunotherapy to better inform treatment decision-making for patients with gastroesophageal cancers
2. Use AJCC or other appropriate staging in clinical practice, including the use of appropriate prognostic indicators and evidence-based national guidelines for treatment planning
3. Evaluate the basic science of immune therapy for GI malignancies and the implications for transfer from bench to bedside
4. Increase knowledge of immunotherapy for neuroendocrine tumors and biomarker identification of novel immunotherapies
5. Identify and implement optimal strategies for managing immune-related side effects and toxicities in patients treated with immunotherapy agents
6. Anticipate the needs, problems, and issues of cancer survivors and develop an individualized wellness plan in partnership with cancer survivors, their families and the healthcare team

To Pay by Check:
Mail payment (with checks made payable to Cedars-Sinai Medical Center) to:
Cedars-Sinai Medical Center
Office of Continuing Medical Education
Attn: Registrations
700 N. San Vicente Boulevard, #G550
West Hollywood, CA 90069

Refund Policy:
All cancellations must be submitted in writing and refunds will be subject to an administrative charge. To view the policy, click here. Please e-mail cancellation request to [email protected]. If you do not receive confirmation of your cancellation via e-mail, please call (310) 423-5548. 

Cedars-Sinai Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement
Cedars-Sinai Medical Center designates this Live Activity for a maximum of 4.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Non-Physician Attendance
A certificate of participation will be provided to other health care professionals requesting credits. Participants should ensure in advance that their credentialing or licensing organization accepts AMA PRA Category 1 Credits™.

ABIM MOC Recognition Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.00 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Numerous hotels are available in the area surrounding Cedars-Sinai. Many of these are within a short walking or driving distance from the medical center. The following link contains some of the available nearby options:

https://www.cedars-sinai.org/patients-visitors/nearby/stay.html

Cedars-Sinai Medical Center is also conveniently located near four major airports and Amtrak. The following link contains more information regarding airport shuttle companies, automobile rental companies, bus lines, railways and taxi/ride services:

https://www.cedars-sinai.org/patients-visitors/nearby/getting-around.html

Course Directors
Andrew Hendifar, MD, MPH
Medical Director, Pancreatic Cancer
Samuel Oschin Comprehensive Cancer Institute
Assistant Professor, Medicine
Cedars-Sinai

Jun Gong, MD
IM/Hematology/Oncology
Samuel Oschin Comprehensive Cancer Institute
Cedars-Sinai

Guest Faculty
Ghassan Abou-Alfa, MD
Memorial Sloan Kettering Cancer Center

Emily Bergsland
University of California, San Francisco

Omid Hamid, MD
The Angeles Clinic & Research Institute

Samuel Klempner, MD
Massachusetts General Hospital

Eileen O’Reilly, MD
Memorial Sloan Kettering Cancer Center

Richard Tuli, MD, PhD
Memorial Sloan Kettering Cancer Center

Alexandra Gangi, MD
Shelly Lu, MD
Nicholas Nissen, MD
Brennan Spiegel, MD

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Jun Gong, MD
Cedars-Sinai

Activity Course Director, Faculty

Consulting Fee-Amgen|Consulting Fee-Astellas Pharma|Consulting Fee-Clinical Congress Consultants|Consulting Fee-Elsevier|Consulting Fee-Exelixis Inc.|Consulting Fee-QED Therapeutics

Andrew E. Hendifar, MD
Cedars-Sinai

Activity Course Director, Faculty

Ghassan Abou-Alfa, MD
Memorial Sloan Kettering Center

Faculty

Emily Bergsland, MD
University of California, San Francisco

Faculty

Contracted Research-Merck and Company, Inc.|unpaid -advisory board-Hutchison MediPharma International Inc.|Contracted Research-Novartis AG

Alexandra Gangi, MD
Cedars Sinai

Faculty

Nothing to disclose

Omid Hamid, MD
The Angeles Clinic and Research Institute

Faculty

Consulting Fee-Aduro, Akeso, Amgen, Array, Beigene, BMS, Roche Genentech, GSK, Immunocore, Incyte, Janssen, Merck, Nextcure, Novartis, Sanofi Regeneron, Seattle Genetics, Tempus, Zelluna|Speakers Bureau-Array, BMS, Novartis, Sanofi Regeneron|Contracted Research-Contracted Research for Institution-Arcus, Aduro, Akeso, Amgen, Array, BMS, CytomX, Exelixis, Roche Genentech, GSK, Immunocore, Incyte, Iovance, Merck, Moderna, Merck Serono, Nextcure, Novartis, Sanofi Regeneron, Seattle Genetics, Torque, Zelluna

Samuel Klempner, MD
Massachusetts General Hospital

Faculty

Ownership Interest-Turning Point Therapeutics|Consulting Fee-Astellas|Consulting Fee-Eli Lilly and Company|Consulting Fee-Foundation Medicine|Consulting Fee-Bristol-Myers Squibb|Consulting Fee-Boston Biomedical|Consulting Fee-Pieris

Shelly C. Lu, MD
Cedars-Sinai

Faculty

Nothing to disclose

Nicholas Nissen, MD
Cedars-Sinai

Faculty

Nothing to disclose

Eileen O'Reilly, MD
Memorial Sloan Kettering Center

Faculty

Consulting Fee-Agios, Astra Zeneca, Bayer, Beigene, Bioline, BMS, Celgene, CytomX, Debio, Eisai, Exelixis, Flatiron, Genoscience, Incyte, Ipsen, Jansen, LAM, Lilly, Loxo, Merck, MINA, Pfizer, QED, Redhill, Silenseed, Sillajen, Sobi, Targovax, Twoxar, Yiviva

Brennan M. Spiegel, MD, MSHS
Cedars-Sinai

Faculty

Ownership Interest-My Total Health|Royalty-Slack Publishing|Royalty-GI Logic, My Total Health|Receipt of Intellectual Property Rights/Patent Holder-GI Logic, My Total Health|Contracted Research-Ironwood Pharmaceuticals, Nestle Health Sciences, AstraZeneca, Novartis Pharmaceuticals, Takeda Pharmaceuticals, Shire Pharmaceuticals

Rich Tuli, MD
Memorial Sloan Kettering Center

Faculty

Saturday, September 12, 2020

Exhibit Fee: $800 

Should you decide to participate at this important educational activity, please complete the online exhibit registration. 
Online registration is required even if paying by check. An account will need to be created. 

Click the “Register” tab, select your registrant category “Exhibitor/Vendor” and proceed. 

Please email [email protected] for more information.